[ARS] VYNE Therapeutics Inc. SEC Filing

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

ARS

Rhea-AI Filing Summary

Analyzing...

11/12/2025 - 04:13 PM

ARS - VYNE Therapeutics Inc.

ARS Filing - VYNE Therapeutics Inc.

This filing is available as a PDF document.

Filing Type: ARS

Company: VYNE Therapeutics Inc. (VYNE)

Acceptance Date: 2025-11-12T16:13:01.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Vyne Therapeutics Inc

NASDAQ:VYNE

VYNE Rankings

#6077 Ranked by Market Cap

N/A Ranked by Dividends

VYNE Latest News

Dec 17, 2025

VYNE Therapeutics and Yarrow Bioscience Announce Merger Agreement

Nov 6, 2025

VYNE Therapeutics Reports 2025 Third Quarter Financial Results and Provides Business Update

Aug 14, 2025

VYNE Therapeutics Reports 2025 Second Quarter Financial Results and Provides Business Update

Jul 30, 2025

VYNE Therapeutics Announces Topline Results from Phase 2b Trial with Repibresib Gel in Nonsegmental Vitiligo

Jul 2, 2025

VYNE Therapeutics Provides Program Update on Oral BET inhibitor VYN202

VYNE Latest SEC Filings

Jan 30, 2026

[425] VYNE Therapeutics Inc. Business Combination Communication

Jan 30, 2026

[8-K] VYNE Therapeutics Inc. Reports Material Event

Dec 17, 2025

[425] VYNE Therapeutics Inc. Business Combination Communication

Dec 12, 2025

[8-K] VYNE Therapeutics Inc. Reports Material Event

Dec 15, 2025

[Form 4] VYNE Therapeutics Inc. Insider Trading Activity

VYNE Stock Data

Market Cap 19.97M

Float 31.76M

Industry Biotechnology

Sector Pharmaceutical Preparations

Website Link

Country United States

City BRIDGEWATER